Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in Patients With Retroperitoneal Disease and Hypertension
NCT06829134 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 246
Last updated 2025-02-17
Summary
The primary objective of this study is to evaluate the efficacy and safety of laparoscopic renal artery nerve blockade surgery in patients with retroperitoneal diseases complicated by hypertension.
The study aims to address the following two questions:
1. Can laparoscopic renal artery perivascular nerve blockade reduce postoperative blood pressure and decrease the dependence on antihypertensive medications in patients with retroperitoneal diseases and hypertension?
2. What is the safety profile of the procedure, and does it lead to any complications?
The researchers will randomly assign patients to the experimental group and the control group. The experimental group will undergo surgery related to the primary disease in addition to laparoscopic renal artery perivascular nerve blockade, while the control group will only receive surgery related to the primary disease. This design allows for a comparison of the effects of renal artery perivascular nerve blockade on postoperative blood pressure.
Participants will:
1. Patients will undergo either surgery related to the primary disease combined with renal artery perivascular nerve blockade, or surgery related to the primary disease alone.
2. For the three months following surgery, the antihypertensive medication regimen will remain unchanged from the preoperative plan. At the end of the three-month period, patients will visit the hospital for 24-hour ambulatory blood pressure monitoring.
Conditions
- Hypertension
- Retroperitoneal Disease
Interventions
- PROCEDURE
-
laparoscopic renal artery perivascular nerve blockade
1. When only the main renal artery is present: The complete dissection of the renal artery should be performed in the distal 2/3 portion, close to the renal hilum. The connective tissue and nerve tissue within a 1 cm radius from the center of the renal artery lumen must be completely separated (using instruments such as an ultrasonic scalpel or monopolar hook, etc.). The length of the dissected renal artery should be at least 0.5 cm, forming a dissection ring. 2. When accessory renal arteries are present: In addition to the main renal artery meeting the aforementioned standards, the accessory renal arteries must also be dissected. The radius of the dissection ring should be 0.7 cm, with a length ranging from 0.3 to 0.5 cm. 3. When renal polar arteries are present: Dissection may be performed appropriately based on the surgical conditions. 4. The prerequisite is to ensure the safety of the surgery, specifically the safe resection of the primary lesion.
- PROCEDURE
-
surgery related to the primary disease
The surgeries related to the primary disease include laparoscopic partial nephrectomy, laparoscopic adrenalectomy, and other similar procedures.
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-01
- Primary Completion
- 2026-03-01
- Completion
- 2026-12-01
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension
NCT06783296 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension
NCT02346045 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control
NCT01932450 ·Status: UNKNOWN ·Phase: PHASE2
-
"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDN
NCT07273877 ·Status: ENROLLING_BY_INVITATION
-
Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation
NCT02164435 ·Status: UNKNOWN ·Phase: NA
-
Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension
NCT01737138 ·Status: UNKNOWN ·Phase: NA
-
Renal Denervation for Uncontrolled Hypertension
NCT02016573 ·Status: WITHDRAWN ·Phase: NA
-
Renal Denervation in Patients With Uncontrolled Hypertension in Chinese
NCT01390831 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Transcatheter Renal Artery Sympathetic Denervation Observational Study
NCT05744986 ·Status: UNKNOWN
-
Laparoscopic Adventitial Renal Denervation (RDN) for Refractory Hypertension
NCT07108829 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Randomized Comparison of Ultrasound Versus Radiofrequency Denervation in Patients With Therapy Resistant Hypertension
NCT02920034 ·Status: COMPLETED ·Phase: NA
-
Renal Denervation for Treatment of Resistant Hypertension in Patients With Chronic Kidney Disease
NCT01747382 ·Status: NO_LONGER_AVAILABLE
-
Denervation of the REnal Artery in Metabolic Syndrome
NCT01465724 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives
NCT04531124 ·Status: NOT_YET_RECRUITING
-
The Predictive Role of Proteomics in Blood Pressure Response of Hypertensive Patients Undergoing Renal Denervation.
NCT06208501 ·Status: RECRUITING
-
Netrod-Pilot Study of Renal Denervation With NetrodTM Sixelectrode Radiofrequency RDN System
NCT07061054 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension
NCT03511313 ·Status: UNKNOWN ·Phase: NA
-
Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension
NCT01644604 ·Status: COMPLETED ·Phase: NA
-
Sympathetic Mapping/ Ablation of Renal Nerves Trial (SMART) HTN-OFF MED Study
NCT03885843 ·Status: UNKNOWN ·Phase: NA
-
Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
NCT01850901 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Parathyroidectomy on Renal Function, Endothelial Function, and Blood Pressure
NCT00452049 ·Status: UNKNOWN
-
Clinical Study on the Efficacy of Microvascular Decompression in the Treatment of Neurogenic Hypertension
NCT04791410 ·Status: UNKNOWN
-
Renal Denervation in Patients With Refractory Hypertension
NCT00753285 ·Status: COMPLETED ·Phase: NA
-
Renal Sympathetic Denervation in Mild Refractory Hypertension
NCT01656096 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Nerve Denervation(RDN) and Renal Function
NCT05612906 ·Status: RECRUITING